Logo image
The evolution of three decades of antiretroviral therapy: Challenges, triumphs and the promise of the future
Journal article   Open access   Peer reviewed

The evolution of three decades of antiretroviral therapy: Challenges, triumphs and the promise of the future

A. Tseng, J. Seet and E.J. Phillips
British Journal of Clinical Pharmacology, Vol.79(2), pp.182-194
2015
pdf
evolution_of_three_decades.pdfDownloadView
Author’s Version Open Access
url
Free to Read *No subscription requiredView

Abstract

The evolution of HIV treatment has improved our understanding and management of complex pharmacological issues that have driven improved outcomes and quality of life of the HIV-infected patient. These include adherence, long and short-term toxicities, pharmacoenhancement, pharmacogenomics, therapeutic drug monitoring (TDM), differential penetration of drugs into sanctuary sites such as the central nervous system (CNS), genital tract and small bowel and drug-drug and drug-food interactions related to cytochrome P450 drug metabolizing enzymes, UGT1A1 and drug transporters to name a few. There is future promise as an increased understanding of the immunopathogenesis of HIV and global public health initiatives are driving novel treatment approaches with goals to prevent, control and ultimately eradicate HIV.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

262 File views/ downloads
94 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.66 HIV
1.66.11 HIV/AIDS Prevention
Web Of Science research areas
Pharmacology & Pharmacy
ESI research areas
Pharmacology & Toxicology
Logo image